![](https://hsomm.gr/wp-content/uploads/2018/12/artcle-spinger-150x150.jpg)
Pulmonary mucormycosis presenting as a tumor-like mass in an uncontrolled diabetic patient: a rare case report.Hello world!
8 Ιουλίου, 2024Development of a monoclonal antibody and a lateral-flow device for the rapid detection of a Mucorales-specific biomarker.
Invasive mucormycosis (IM) is associated with high mortality and morbidity and
Mucoromycosis is a highly aggressive angio-invasive disease of humans caused by fungi in the zygomycete order, Mucorales. While Rhizopus arrhizus is the principal agent of mucoromycosis, other Mucorales fungi including Apophysomyces, Cunninghamella, Lichtheimia, Mucor, Rhizomucor and Syncephalastrum are able to cause life-threatening rhino-orbital-cerebral, pulmonary, gastro-intestinal and necrotising cutaneous infections in humans. Diagnosis of the disease currently relies on non-specific CT, lengthy and insensitive culture from invasive biopsy, and time-consuming histopathology of tissue samples. At present, there are no rapid antigen tests that detect Mucorales-specific biomarkers of infection, and which allow point-of-care diagnosis of mucoromycosis. Here, we report the development of an IgG2b monoclonal antibody (mAb), TG11, which binds to extracellular polysaccharide (EPS) antigens of between 20 kDa and 250 kDa secreted during hyphal growth of Mucorales fungi… read more